Abera Bioscience AB (NGM: ABERA)
Health Care · Biotechnology · SE
Skr—
— today · — 1Y
Abera Bioscience AB (NGM: ABERA) operates in the Biotechnology industry within the Health Care sector. The company is valued at $14.09M.
trading between 5.15 and 10.05.
Tweenvest scores Abera Bioscience AB across four factors: quality 44/100, value 45/100. Its strongest factor is value.
ABERA price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $14.09M
- Revenue (TTM)
- $938.50K
- P/E
- —
- EPS
- -1.14
- Dividend yield
- —
- Beta (5Y)
- 0.79
- 52-week high
- Skr10.05
- 52-week low
- Skr5.15
- Avg volume (3M)
- —
- Shares outstanding
- 20.50M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| FunPep Company LimitedTSE: 4881 | $14.44M | ¥45.00 | +2.27% |
| NewcelX Ltd.NasdaqCM: NCEL | $14.44M | $2.50 | -17.90% |
| Aptamer Group PLCAIM: APTA | $14.29M | £0.00 | -4.62% |
| Allarity Therapeutics, Inc.NasdaqCM: ALLR | $14.24M | $0.90 | -9.60% |
| Pasithea Therapeutics Corp.NasdaqCM: KTTA | $14.03M | $0.42 | -10.16% |
| Xintela AB (publ)OM: XINT | $14.00M | Skr0.16 | -10.31% |
| BioCardia, Inc.NasdaqCM: BCDA | $13.93M | $0.92 | -11.53% |
| Biophytis S.A.ENXTPA: ALBPS | $13.57M | €0.03 | +8.81% |
Figures last refreshed Oct 18, 2026.